| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
B by Bcr-Abl in Bcr-Abl+ Human Myeloid Leukemia Cells
Departments of 1 Internal Medicine I and 2 Internal Medicine III, University of Ulm, Germany, and 3 Afdeling Biochemie, Katholieke Universiteit Leuven, Leuven, Belgium
The Bcr-Abl tyrosine kinase activates various signaling pathways including nuclear factor
B that mediate proliferation, transformation, and apoptosis resistance in Bcr-Abl+ myeloid leukemia cells. Here we report that protein kinase (PK) D2, a serine threonine kinase of the PKD family, is a novel substrate of Bcr-Abl. PKD2 was found to be the major isoform of the PKD family expressed in chronic myeloid leukemia cells and is tyrosine phosphorylated by Bcr-Abl in its pleckstrin homology domain. A mutant that mimicks tyrosine phosphorylation of PKD2 in the pleckstrin homology domain activates nuclear factor
B independently of its catalytic activity. Furthermore, our data show that Bcr-Ablinduced activation of the nuclear factor
B cascade in LAMA84 cells is largely mediated by tyrosine-phosphorylated PKD2. These data present a novel mechanism of Bcr-Ablinduced nuclear factor
B activation in myeloid leukemia. Targeting PKD2 tyrosine phosphorylation, not its kinase activity, could be a novel therapeutic approach for the treatment of Bcr-Abl+ myeloid leukemia.
This article has been cited by other articles:
![]() |
J. Sinnett-Smith, R. Jacamo, R. Kui, Y. M. Wang, S. H. Young, O. Rey, R. T. Waldron, and E. Rozengurt Protein Kinase D Mediates Mitogenic Signaling by Gq-coupled Receptors through Protein Kinase C-independent Regulation of Activation Loop Ser744 and Ser748 Phosphorylation J. Biol. Chem., May 15, 2009; 284(20): 13434 - 13445. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Hao, L. Wang, Z. J. Zhao, and H. Tang Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis J. Biol. Chem., January 9, 2009; 284(2): 799 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yuan, A. Lugea, L. Zheng, I. Gukovsky, M. Edderkaoui, E. Rozengurt, and S. J. Pandol Protein kinase D1 mediates NF-{kappa}B activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1190 - G1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Monteghirfo, F. Tosetti, C. Ambrosini, S. Stigliani, S. Pozzi, F. Frassoni, G. Fassina, S. Soverini, A. Albini, and N. Ferrari Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-{kappa}B and p53 modulation Mol. Cancer Ther., September 1, 2008; 7(9): 2692 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jacamo, J. Sinnett-Smith, O. Rey, R. T. Waldron, and E. Rozengurt Sequential Protein Kinase C (PKC)-dependent and PKC-independent Protein Kinase D Catalytic Activation via Gq-coupled Receptors: DIFFERENTIAL REGULATION OF ACTIVATION LOOP SER744 AND SER748 PHOSPHORYLATION J. Biol. Chem., May 9, 2008; 283(19): 12877 - 12887. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Doppler and P. Storz A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation J. Biol. Chem., November 2, 2007; 282(44): 31873 - 31881. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Bhende, S. J. Dickerson, X. Sun, W.-H. Feng, and S. C. Kenney X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D J. Virol., July 15, 2007; 81(14): 7363 - 7370. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Feng, M. Ren, and C. S. Rubin Conserved Domains Subserve Novel Mechanisms and Functions in DKF-1, a Caenorhabditis elegans Protein Kinase D J. Biol. Chem., June 30, 2006; 281(26): 17815 - 17826. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Feng, M. Ren, S.-L. Wu, D. H. Hall, and C. S. Rubin Characterization of a Novel Protein Kinase D: CAENORHABDITIS ELEGANS DKF-1 IS ACTIVATED BY TRANSLOCATION-PHOSPHORYLATION AND REGULATES MOVEMENT AND GROWTH IN VIVO J. Biol. Chem., June 30, 2006; 281(26): 17801 - 17814. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Matthews, P. Liu, M. Spitaler, E. N. Olson, T. A. McKinsey, D. A. Cantrell, and A. M. Scharenberg Essential Role for Protein Kinase D Family Kinases in the Regulation of Class II Histone Deacetylases in B Lymphocytes Mol. Cell. Biol., February 15, 2006; 26(4): 1569 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Auer, J. von Blume, S. Sturany, G. von Wichert, J. Van Lint, J. Vandenheede, G. Adler, and T. Seufferlein Role of the Regulatory Domain of Protein Kinase D2 in Phorbol Ester Binding, Catalytic Activity, and Nucleocytoplasmic Shuttling Mol. Biol. Cell, September 1, 2005; 16(9): 4375 - 4385. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rozengurt, O. Rey, and R. T. Waldron Protein Kinase D Signaling J. Biol. Chem., April 8, 2005; 280(14): 13205 - 13208. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |